Reduced E-cadherin expression is associated with abdominal pain and symptom duration in a study of alternating and diarrhea predominant IBS.
about
Crosstalk between Inflammation and ROCK/MLCK Signaling Pathways in Gastrointestinal Disorders with Intestinal HyperpermeabilityRole of Corticotropin-releasing Factor in Gastrointestinal Permeability.Homeostasis of the gut barrier and potential biomarkers.Expression of G protein-coupled estrogen receptor in irritable bowel syndrome and its clinical significanceIrritable bowel syndrome: a microbiome-gut-brain axis disorder?Gastrointestinal mucosal barrier function and diseases.Gut Microbiota Dysbiosis as Risk and Premorbid Factors of IBD and IBS Along the Childhood-Adulthood Transition.Balance of Autonomic Nervous System Predicts Who Benefits from a Self-management Intervention Program for Irritable Bowel SyndromeGluten-induced symptoms in diarrhea-predominant irritable bowel syndrome are associated with increased myosin light chain kinase activity and claudin-15 expression.Systemic symptoms in irritable bowel syndrome: An investigative study on the role of enterocyte disintegrity, endotoxemia and inflammationCrosstalk at the mucosal border: importance of the gut microenvironment in IBS.Sacral nerve stimulation enhances early intestinal mucosal repair following mucosal injury in a pig model.Irritable bowel syndrome, the microbiota and the gut-brain axis.Disruption of the epithelial barrier during intestinal inflammation: Quest for new molecules and mechanisms.Saccharomyces boulardii CNCM I-745 Restores intestinal Barrier Integrity by Regulation of E-cadherin Recycling.Claudin-2 expression is upregulated in the ileum of diarrhea predominant irritable bowel syndrome patients.Psychological stress-induced colonic barrier dysfunction: Role of immune-mediated mechanisms.KLF-5 extends its fingers to desmosomes: the next frontier for enteric epithelial research?Glucagon-like peptide-1 analog, liraglutide, improves visceral sensation and gut permeability in rats.
P2860
Q28079482-0ABA0146-68CB-4CD6-8C48-AFBEF1DD092EQ30421083-DC52C0EC-FAE7-4CD0-9FA0-3C9191B36A36Q33715804-6107F7E7-5CEC-4191-A2EC-55638D9B109DQ33802912-16731BF1-4475-4162-8EE4-12BDE11406D8Q34366837-4573440F-D983-488D-858A-3C04AAE29969Q34520959-3D4936EA-E79B-4BFC-BCD5-716AFBDB9C57Q35847101-E0532D18-A759-4569-95E2-CAC5523750AAQ36426060-1D3A1933-82E3-4DB4-8BCC-3F399379CCBDQ37559869-9E445187-3312-45D0-94B4-6E9E48F33FC7Q37707660-8D12F17D-6FF4-4AB3-899D-EACDB7A27089Q38275041-B19F6D02-829F-47D1-95B2-39B2C9B19744Q38900423-F9BAFCED-3FA9-4238-B523-31B8A2A040ACQ38912505-F1970C16-305D-4BAB-B068-93E06AE0B574Q39189861-98DEBF26-7D53-4D95-B9DB-2486F2B17310Q40281979-660E1885-24AE-41BB-B1A4-D9717968EB09Q41955092-7A8ECC0E-E127-4528-82D6-B3A9DE757203Q48117039-6CFDCE19-08BE-482F-9BEE-D77A33635901Q48159772-6DE23B73-EB70-44B2-86EA-D13D30E1003AQ50178398-7803D2A6-8E7B-4DEE-9555-B30A2C8D9D87
P2860
Reduced E-cadherin expression is associated with abdominal pain and symptom duration in a study of alternating and diarrhea predominant IBS.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Reduced E-cadherin expression ...... and diarrhea predominant IBS.
@en
Reduced E-cadherin expression ...... and diarrhea predominant IBS.
@nl
type
label
Reduced E-cadherin expression ...... and diarrhea predominant IBS.
@en
Reduced E-cadherin expression ...... and diarrhea predominant IBS.
@nl
prefLabel
Reduced E-cadherin expression ...... and diarrhea predominant IBS.
@en
Reduced E-cadherin expression ...... and diarrhea predominant IBS.
@nl
P2093
P2860
P356
P1476
Reduced E-cadherin expression ...... and diarrhea predominant IBS.
@en
P2093
E Wilcz-Villega
M O'Sullivan
P2860
P304
P356
10.1111/NMO.12262
P577
2013-11-29T00:00:00Z